Reversible cardiac hypertrophy induced by PEG-coated gold nanoparticles in mice
2016 · Scientific Reports · 57 citations
https://doi.org/10.1038/srep20203
C
Chengzhi Yang
Hunan University(CN)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
80
Papers
1.2K
Citations
19
h-index
31
i10-index
Chengzhi Yang is an academic researcher from Hunan University. The author has contributed to research in topics: Cardiomyopathy and Myosin Studies & Cardiovascular Function and Risk Factors & Cardiovascular Effects of Exercise. The author has an h-index of 19, co-authored 68 publications.
ORCID: 0000-0003-3171-421XPapers by this author
worksGlobal, regional, and national burdens of heart failure in adolescents and young adults aged 10–24 years from 1990 to 2021: an analysis of data from the Global Burden of Disease Study 2021
2024 · EClinicalMedicine · 26 citations
https://doi.org/10.1016/j.eclinm.2024.102998
Downregulation of β-Adrenoceptors in Isoproterenol-Induced Cardiac Remodeling through HuR
2016 · PLoS ONE · 24 citations
https://doi.org/10.1371/journal.pone.0152005
Gender-related differences in the association between serum uric acid and left ventricular mass index in patients with obstructive hypertrophic cardiomyopathy
2016 · Biology of Sex Differences · 20 citations
https://doi.org/10.1186/s13293-016-0074-x
Efficacy and safety of aspirin and rivaroxaban for venous thromboembolism prophylaxis after total hip or knee arthroplasty
2020 · Medicine · 20 citations
https://doi.org/10.1097/md.0000000000023055
Quantitative fragmented QRS has a good diagnostic value on myocardial fibrosis in hypertrophic obstructive cardiomyopathy based on clinical-pathological study
2020 · BMC Cardiovascular Disorders · 15 citations
https://doi.org/10.1186/s12872-020-01590-2
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat